Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Communications Medicine
|
May 17, 2025
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination
Xammy Huu Wrynla, Timothy A Bates, Mila Trank-Greene, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 20, 2022
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
Marcel E Curlin, Timothy A Bates, Gaelen Guzman, et al.
Med (New York, N.Y.)
|
October 5, 2022
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
Marcel E Curlin, Timothy A Bates, Gaelen Guzman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 4, 2025
Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicity
Xammy H Wrynla, Timothy A Bates, Mila Trank-Greene, et al.
JAMA
|
July 21, 2021
Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples
Timothy A Bates, Hans C Leier, Zoe L Lyski, et al.
Journal of Natural Products
|
January 10, 2022
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
Richard B van Breemen, Ruth N Muchiri, Timothy A Bates, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2023
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
Timothy A Bates, Hans C Leier, Savannah K McBride, et al.
JCI Insight
|
January 26, 2023
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
Timothy A Bates, Hans C Leier, Savannah K McBride, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2022
A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants
Scotland E Farley, Jennifer E Kyle, Hans C Leier, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 2, 2026
An MR1-specific nanobody capable of blocking MR1T cell activation
Timothy A Bates, Corinna A Kulicke, Sintayehu K Gurmessa, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Communications Medicine
|
May 17, 2025
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination
Xammy Huu Wrynla, Timothy A Bates, Mila Trank-Greene, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 20, 2022
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
Marcel E Curlin, Timothy A Bates, Gaelen Guzman, et al.
Med (New York, N.Y.)
|
October 5, 2022
Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
Marcel E Curlin, Timothy A Bates, Gaelen Guzman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 4, 2025
Immune imprinting and vaccination interval underly XBB.1.5 monovalent vaccine immunogenicity
Xammy H Wrynla, Timothy A Bates, Mila Trank-Greene, et al.
JAMA
|
July 21, 2021
Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples
Timothy A Bates, Hans C Leier, Zoe L Lyski, et al.
Journal of Natural Products
|
January 10, 2022
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
Richard B van Breemen, Ruth N Muchiri, Timothy A Bates, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2023
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
Timothy A Bates, Hans C Leier, Savannah K McBride, et al.
JCI Insight
|
January 26, 2023
An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
Timothy A Bates, Hans C Leier, Savannah K McBride, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2022
A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants
Scotland E Farley, Jennifer E Kyle, Hans C Leier, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 2, 2026
An MR1-specific nanobody capable of blocking MR1T cell activation
Timothy A Bates, Corinna A Kulicke, Sintayehu K Gurmessa, et al.
Page
of 4